|Product Overview:||Recombinant Mouse Fasl(Gln101-Leu279) fused with HA tag at N-terminal was expressed in CHO.|
|Predicted N Terminal:||Tyr|
|Form:||Lyophilized from a 0.2 μm filtered solution in PBS with BSA as a carrier protein.|
|Bio-activity:||Measured by its ability to induce apoptosis of Jurkat human acute T cell leukemia cells. The ED50 for this effect is typically 1-8 ng/mL in the presence of 2.5 µg/mL of a cross-linking antibody, Mouse Anti-Hemagglutinin/HA Peptide Monoclonal Antibody.|
|Molecular Mass:||Predicted Molecular Mass: 25.9 (monomer) kDa;
SDS-PAGE: 40-55 kDa, reducing conditions.
|Endotoxin:||<0.01 EU per 1 μg of the protein by the LAL method.|
|Purity:||>95%, by SDS-PAGE under reducing conditions and visualized by silver stain|
|Storage:||Avoid repeated freeze-thaw cycles.
12 months from date of receipt, -20 to -70 centigrade as supplied.
1 month, 2 to 8 centigrade under sterile conditions after reconstitution.
3 months, -20 to -70 centigrade under sterile conditions after reconstitution.
|Reconstitution:||Reconstitute at 100 μg/mL in PBS containing at least 0.1% human or bovine serum albumin.|
|Gene Name:||Fasl Fas ligand (TNF superfamily, member 6) [ Mus musculus ]|
|Synonyms:||FASL; Fas ligand (TNF superfamily, member 6); tumor necrosis factor ligand superfamily member 6; CD95 ligand; Fas antigen ligand; generalized lymphoproliferative disease; gld; CD178; CD95L; Fas-L; Faslg; CD95-L; Tnfsf6; APT1LG1;|